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ABSTRACT
Introduction: The cause of demise in GBS may be related to the sequelae of complications associated with the disease
or its treatment. The primary objective of this study was to enumerate the prevalence of complications associated with
treatment of patients with GBS at a tertiary care setup in Islamabad. The secondary objective was to determine the
antibiotic susceptibility patterns of commonly encountered infections in GBS during hospital stay in our setup.
Materials and methods: The study was carried out between Jan 2014 and June 2015 on one hundred patients of GBS
aged ≥ 12 years. Baseline characteristics, complications and antibiotic sensitivity patterns were recorded. Results:
Major complication exclusively in plasma exchange group was that of hypoalbuminemia (22, 22%) and large venous
catheter infections (6, 6%). None had IVIG related complications. Respiratory tract infections were predominantly
experienced by those admitted in ICU (p=0.00). Likelihood of having complications was unrelated to age, gender,
duration of illness or duration of hospital stay (p>0.05) when using standard safety protocols. Safe antibiotics showing
high sensitivity patterns to commonly acquired infections in GBS patients included Vancomycin (100%), Polymixin B
(100%) and Tigecycline (62.5%). Conclusions: Age, gender, duration of illness or duration of hospital stay do not
affect the complication rates in GBS when using standard safety protocols. Respiratory tract infections commonly
affect those admitted to ICU. Large venous access catheters should be regularly inspected for infections. Antibiotics
which may empirically be used in our setup for common infections complicating GBS include Vancomycin, Polymixin B
and Tigecycline (particularly for RTIs) as these are highly sensitive and easily available.
Keywords:
Guillain-Barré syndrome; complications; duration of hospital stay; duration of illness, infections, antibiotics, sensitivity,
resistance.

INTRODUCTION

monitoring in patients with an increased risk profile or
by reducing rates of complications.5,6 Patients affected
with severe forms of Guillain-Barré syndrome require
intensive care. In the intensive care unit (ICU),
interventions, lines and assisting devices may increase
morbidity.7 Contrary to the established belief that the
disease has a favorable outcome, several
hospital-treated patients may still expire or present with
residual deficit even several months after the onset of
symptoms.8, 9, 10 The cause of death and disability in
this illness may be related to the sequelae of
complications associated with the disease or its
treatment. Unfortunately, very scarce local data
regarding these complications is currently available.

Guillain-Barré syndrome (GBS) is the most common
cause of acute flaccid paralysis and should be
considered early in all patients presenting with flaccid
quadriparesis.1 It has a dismal prognosis with almost
20% of patients experiencing severe long-term
disability and up to 5% of patients dying even after
receiving appropriate therapy.2, 3, 4
In the elderly and severely affected patients, death after
GBS predominantly occurs during the recovery phase.
Future research work is needed to ascertain whether
the mortality of GBS can be reduced by intensive
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vascular diseases, myopathy, motor neuron disorders,
any genetic or other disorders affecting nerve and
muscles, CIDP (Chronic Inflammatory Demyelinating
Polyneuropathy) and diabetic peripheral neuropathy
were excluded. People were offered plasma exchange
(PE), Intravenous Immunoglobulin (IVIG), PE followed
by IVIG or none accordingly. Complications of treatment
or supportive care were recorded including large venous
catheter infections, RTI (Respiratory Tract Infection),
UTI (Urinary Tract infection), DVT (Deep Venous
Thrombosis), bed sores etc. In case of an infection,
source of infection was ascertained via culture results
or supportive evidence (like chest x-ray in case of RTI).
Antibiotic sensitivity and resistance patterns were
recorded from the results from pathology laboratory
PIMS using standard methods of culture and sensitivity.
No prophylactic antibiotics were used in any of the
patients. Standard safety protocols for treatment and
management were used in all circumstances.

Nonetheless, timely recognition and prompt
management of these complications is of paramount
importance. The primary objective of this study was to
enumerate the prevalence of complications associated
with treatment of patients with GBS at a tertiary care
setup in Islamabad. The secondary objective was to
determine the antibiotic susceptibility patterns of
commonly encountered infections during hospital stay.
A comprehensive statistical knowledge of the above
may help to reduce morbidity associated with GBS.
MATERIAL AND METHODS
This study was a cross-sectional, observational,
descriptive study carried out on indoor patients of GBS
at Department of Neurology, Pakistan Institute of
Medical Sciences (PIMS), Islamabad. The study was
carried out from 1st Jan 2014 to 30th June 2015. One
hundred patients of GBS aged ≥ 12years were
included.

The data was analyzed using SPSS version 16.0. Mean
and standard deviation were calculated for numerical
variables. Frequencies and percentages were
calculated for categorical variables. Chi-square (x2) test
was used for categorical variables and odds ratio and p
values were calculated for complications against
baseline characteristics. P value < 0.05 was taken
statistically significant. Antibiotic sensitivity and
resistance patterns were presented in graphical forms.

This study was an independent project of the
department and was not funded by any pharmaceutical
organization. The study was reviewed by ethics
committee and performed in accordance with the
ethical standards laid down in an appropriate version of
the 2000 Declaration of Helsinki as well as the
Declaration of Istanbul 2008. Patients fulfilling the
inclusion criteria were enrolled after taking informed
written consent from the patients and/ or relatives. All
the patients were admitted when they first presented to
our center without delay. Criterion for GBS was
ascertained according to Brighton Collaboration
criterion for GBS (clinical, laboratory and NCS (nerve
conduction studies)/EMG (electromyography)11 and
following information was collected: age, gender,
duration of illness, duration of hospital stay, history of
preceding illness, routine laboratory tests (complete
blood counts, liver function tests, serum albumin (both
baseline and at end of PE sessions), renal function
tests, blood sugar random, serum electrolytes, urine
routine examination, urine culture, blood cultures,
arterial blood gases (ABGs), electrocardiogram, chest
x-rays,
toxicology
screen,
ESR
(Erythrocyte
Sedimentation Rate), CPK (Creatine Phospho Kinase),
LDH (Leukocyte DeHydrogenase), hepatitis screening)
and electrodiagnostic tests i-e-, nerve conduction
studies and electromyography, using Cadwell Sierra II
Wedge NCS EMG machine. Electrodiagnostic tests
were performed in all patients by a neurologist. Lumbar
puncture was done for CSF R/E (cerebrospinal fluid
routine examination) in all patients consenting.
Patients with alcoholism, any trauma affecting muscles
or nerves, renal or metabolic dysfunctions, peripheral

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

RESULTS
Mean age was 33.58 ± 18.3 years; with an age range
of 12-75 years. Out of 100, 74 (74%) were males with
a male to female ratio of 2.8: 1. Most of the patients
were quadriparetic and bed bound at presentation;
(n=68 out of 95 quadriparetic; total 68 of 98 with limb
weakness). Eighteen (18%) patients had respiratory
failure (type I/II) and 24 (24%) had dysautonomic
features (mainly labile blood pressure and tachycardia)
leading to death in one patient secondary to ventricular
arrhythmia (fatality rate=1%). Seven (7%) patients had
treatment
(supportive
or
targeted)
related
complications. The major complication in the plasma
exchange group was that of hypoalbuminemia (22,
22%) and large venous catheter infections (6, 6%)
exclusively. None had IVIG related complications. Other
common complications during hospital stay included
RTI (12, 12%), UTI (11, 11%) (Table 1).
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Table 1: Baseline characteristics of GBS patients
Variable

Total individuals % (n)/
mean ± SD

Age
Duration of illness
Duration of hospital stay
Identified preceding events
Fever
RTI
Diarrhea
Treatment offered
None/ observation
Plasmaphresis
IVIG
Plasmaphresis + IVIG
Complications
Yes
No
Pattern of complications
None
Hypoalbuminemia (PE)
Respiratory tract infection (PE/IVIG)
Urinary tract/catheter infection (PE/IVIG)
Venous catheter infections (PE)
Hypotension during PE
Fever with no identifiable source
(PE/IVIG)
Bed sores (PE/IVIG)
DVT (PE/IVIG)
Aseptic meningitis (IVIG)
Renal failure (IVIG)
Anaphylaxis( IVIG)
Encephalopathy (IVIG)

33.58 ± 18.3
8.6 ± 6.9
29.5 ± 38.1

Gender distribution of baseline
characteristics
Males % (n)
Females % (n)
33.3 ± 18.1
34.12 ± 18.9
8.3 ± 7.6
9.11 ± 6.05
27.67 ± 41.3
31.25 ± 45.9

20 (20)
21 (21)
18 (18)

11 (11)
17 (17)
11 (11)

9 (9)
4 (4)
7 (7)

4 (4)
92 (92)
3 (3)
1 (1)

1 (1)
69 (69)
3 (3)
1 (1)

3 (3)
23 (23)
0 (0)
0 (0)

20 (20)
80 (80)

14 (14)
60 (60)

6 (6)
20 (20)

80 (80)
22 (22)
12 (12)
11 (11)
6 (6)
2 (2)
2 (2)

60 (60)
13 (13)
10 (10)
6 (6)
3 (3)
1 (1)
1 (1)

20 (20)
9 (9)
2 (2)
5 (5)
3 (3)
1 (1)
1 (1)

1 (1)
1 (1)
0 (0)
0 (0)
0 (0)
0 (0)

1 (1)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)

0 (0)
1 (1)
0 (0)
0 (0)
0 (0)
0 (0)

RTI=Respiratory Tract Infection (including tracheal
secretions via tracheostomy or endotracheal tube),
UTI=Urinary Tract Infection, CVP=Central venous
Pressure line.
Safe antibiotics showing high sensitivity patterns to
commonly acquired infections in GBS patients included
Vancomycin (100%), Polymixin B (100%) and
Tigecycline (62.5%).
DISCUSSION
Patients of GBS are mostly confined to bed at the time
of presentation to health care facilities. They develop
the complications of immobility as well as complications
related to targeted treatment which is at times
challenging. Complications of plasma exchange include
hypotension,
septicemia,
hypocalcaemia,
and
abnormal clotting. It may particularly be hazardous in
hemodynamically unstable patients.4 Cardiac arrest as
a result of autonomic dysfunction is the commonest
cause of death and accounts for about 20–30% of
deaths. Other causes of death include chest infection,
pulmonary embolism, and respiratory failure. 4
According to this study death occurred only in 1% of
patients because of autonomic dysfunction leading to
ventricular arrhythmia and eventual cardiac arrest. To
understand the spectrum of morbidity associated with
ICU care, a group of authors studied 114 patients with
GBS. Major morbidity occurred in 60% of patients.
Complications were uncommon if ICU stay was less
than 3 weeks. Respiratory complications such as
pneumonia and tracheobronchitis occurred in half of
the patients and were linked to mechanical ventilation.
Systemic infection occurred in one-fifth of patients and
was more frequent with increasing duration of ICU
admission. Direct complications of treatment and
invasive procedures occurred infrequently.6 According to
Henderson et al. other causes of morbidity in a tertiary
center ICU are uncommon. According to another study,
approximately one third of patients with GBS need to be
admitted to the ICU) because of respiratory failure.8
According to this study less than one fifth (18 out of
100; 18%) of patients had respiratory failure and
needed ICU care. In a study carried out by Van den Berg
and associates, out of 527, 15 patients (2.8%) died on
6 months of follow up at highly variable times during the
course of disease. Only 3 out of 15 patients (20%) died
during the acute progressive phase, ten out of 15
(67%) during the recovery phase after neurologic
improvement, most frequently from respiratory or
cardiovascular complications. Eleven out of 15 patients
(73%) were admitted to an intensive care unit during
the course of disease, but only 7 out of these (47%)

Respiratory tract infections were predominantly
experienced by those spending some time in ICU
setting (10 out of 12; 83%) (p=0.00). Likelihood of
having complications was unrelated to age, gender,
duration of illness or duration of hospital stay (p>0.05)
when using standard protocols (Table 2).
Table 2: Relationship of complications to baseline
characteristics and disease parameters
Variable
Age
Age groups
12-30
31-50
51-70
>70
Gender

Male
Female
Duration of illness
Duration of hospital stay
Identified preceding events
Fever
RTI
Diarrhea

% (n)With complications
-

OR
-

P value
0.05

11 (11)
6 (6)
3 (3)
0 (0)
14 (14)
6 (6)
-

0.71
0.71
0.71
0.71
0.20
10.34
4.00

0.87

6 (6)
5 (5)
6 (6)

1.56
0.24
2.43

0.21
0.62
0.11

0.64
0.41
0.40

Organisms commonly isolated from cultures included
Klebsiella, Pseudomonas and Acinetobacter (Table 3).
Table 3: Culture patterns of organisms in patients of
GBS complicated by infections
Organism
Pseudomonas Spp.
Proteus Spp.
Enterobacter Spp.
Acinetobacter
Staphylococcus epidermidis
Staphylococcus aureus
Streptococcus pneumoniae
MRSA
Candida Spp.
Escherichia coli
KlebsiellaPneumoniae

Yes n (%)
9 (9)
4 (4)
2 (2)
9 (9)
3 (3)
6 (6)
1 (1)
3 (3)
2 (2)
6 (6)
11 (11)

No n (%)
91 (91)
96 (96)
98 (98)
91 (91)
97 (97)
94 (94)
99 (99)
97 (97)
98 (98)
94 (94)
89 (89)

Source
RTI/UTI/Chest drain/ Bed sore pus/Blood
Chest drain/RTI/UTI/ Bed sore pus
RTI/UTI
RTI/UTI/ Bed sore pus/CVP tip
CVP tip/Chest drain/UTI/Blood/RTI/Bed sore pus
Chest drain/RTI/Blood/CVP tip/ Bed sore pus
RTI
Blood/CVP tip
UTI
RTI/UTI/Chest drain
UTI/RTI/ Bed sore pus/CVP tip/Chest drain

Table 3: Culture patterns of organisms in patients of
GBS complicated by infections: Spp=species,
MRSA=Methicillin Resistant Staphylococcus aureus,
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died in the intensive care unit. In comparison, out of the
18 (18%) of our patients admitted in ICU, only one (5%;
I out of 18) died. The documented overall mortality rate
when compared among four Asian countries is 6%, with
a range of 0 to 13%. According to Wong et al. leading
causes of death include respiratory infections, followed
by myocardial infarction.9 Compared to that, our fatality
rate of 1% overall is quite small. Moreover, that did not
result from infections but was a consequence of cardiac
arrest.

physiologic change, technique-related complications,
and vascular access-related complications. 2, 5, 6, 7 None
of our patients, however, had fatal complications
related to PE (Table 1).
General care related complications:
Respiratory tract infections were predominantly
experienced by those patients who had been retained in
ICU setting (10 out of 12; 83%) (p=0.00). It implies
that while patients have to be shifted to ICU in view of
impending respiratory failure, they should be
assiduously monitored for developing RTI. These
patients have a weak cough reflex and have difficulty
expectorating airway secretions which renders their
lower
airways
susceptible
to
harvesting
micro-organisms. 5, 6, 9 The chances of developing DVT
or bed sores if following standard protocols, were very
trivial (I case each; 1%). Having said that, the likelihood
of developing these complications was unrelated to
age, gender, duration of illness or duration of hospital
stay (p>0.05) when using standard protocols (Table 1
and 2).

Intravenous immunoglobulins relatedcomplications:
Immunomodulatory treatment may lead to adverse
effects like malaise, myalgia, fever, chills, vasomotor
symptoms, headache, nausea, vomiting, transient
increase in liver enzymes, renal tubular necrosis, acute
renal failure, aseptic meningitis, hypercoagulable state,
anaphylaxis, rashes, encephalopathy.2,4 In this study, no
complications occurred with IVIG treatment. However,
our study, in this regard, is limited as majority of our
patients due to financial constraints opted for plasma
exchange rather than the much expensive IVIG
treatment (Table 1).

Cultures and antibiotic susceptibilities:

Plasma exchange related complications:

Organisms commonly isolated from cultures included
Klebsiella, Pseudomonas and Acinetobacter (Table 3)
and these were mostly isolated from the respiratory
tract or urinary tract. Safe antibiotics (with no major
neuromuscular side effect profile) showing most
sensitivity to commonly acquired infections in GBS
patients at our setup included Vancomycin (100%),
Polymixin B (100%) and Tigecycline (62.5%) (Figure 1)

The major complication in the plasma exchange group
was that of hypoalbuminemia (22, 22%) and large
venous catheter infections (6, 6%) exclusively followed
by hypotension (2, 2%). It might be of considerable
notice that loss of protective proteins from blood with
PE itself may render it susceptible to infections via
central lines and loss of useful intravascular volume
with hypoalbuminemia may contribute towards
hypotension. However, despite that almost 1/4th of the
patients had hypoalbuminemia during exchange
sessions, only a handful got these complications. This is
in light of the fact that we used colloidal solution like
Haemaccel during sessions and not albumin because
none of our patients was able to afford synthetic
albumin infusions. Nonetheless, catheter site infection
of 6% should not be ignored and venous lines should be
regularly inspected for evidence of infection.
Complications associated with PE procedures included
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These statistics are of profound clinical significance
because it is a common practice for physicians to
preferentially prescribe Ceftriaxone and Azarithomycin
to indoor patients especially in the ICU setting.
However, our results showed that the sensitivity of
commonly isolated organisms (Table 3) to these
commonly prescribed antibiotics is poor (least
sensitive) (<26%) (Figure 1 and 2) even when
considered for specific organisms isolated from specific
sites.
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Figure 1: Antibiotic sensitivity patterns for commonly observed nosocomial infections in patients of GBS
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accordingly.

Figure 2: Antibiotic resistance patterns for commonly
observed nosocomial infections in patients of GBS
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